Sökning: WFRF:(Lomnytska Marta) > The protein kinase ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05318naa a2200469 4500 | |
001 | oai:DiVA.org:uu-334429 | |
003 | SwePub | |
008 | 171123s2018 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:229464029 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3344292 URI |
024 | 7 | a https://doi.org/10.18632/oncotarget.237882 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:2294640292 URI |
040 | a (SwePub)uud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Vanlandewijck, Michael,d 1982-u Karolinska Institutet,Uppsala universitet,Science for Life Laboratory, SciLifeLab,Ludwiginstitutet för cancerforskning,Integrated Cardio Metabolic Center, Novum, Karolinska Institute, Huddinge, Sweden4 aut0 (Swepub:uu)micva660 |
245 | 1 0 | a The protein kinase SIK downregulates the polarity protein Par3 |
264 | c 2017-12-31 | |
264 | 1 | b Impact Journals, LLC,c 2018 |
338 | a print2 rdacarrier | |
500 | a Michael Vanlandewijck and Mahsa Shahidi Dadras contributed equally to this work. | |
520 | a The multifunctional cytokine transforming growth factor β (TGFβ) controls homeostasis and disease during embryonic and adult life. TGFβ alters epithelial cell differentiation by inducing epithelial-mesenchymal transition (EMT), which involves downregulation of several cell-cell junctional constituents. Little is understood about the mechanism of tight junction disassembly by TGFβ. We found that one of the newly identified gene targets of TGFβ, encoding the serine/threonine kinase salt-inducible kinase 1 (SIK), controls tight junction dynamics. We provide bioinformatic and biochemical evidence that SIK can potentially phosphorylate the polarity complex protein Par3, an established regulator of tight junction assembly. SIK associates with Par3, and induces degradation of Par3 that can be prevented by proteasomal and lysosomal inhibition or by mutation of Ser885, a putative phosphorylation site on Par3. Functionally, this mechanism impacts on tight junction downregulation. Furthermore, SIK contributes to the loss of epithelial polarity and examination of advanced and invasive human cancers of diverse origin displayed high levels of SIK expression and a corresponding low expression of Par3 protein. High SIK mRNA expression also correlates with lower chance for survival in various carcinomas. In specific human breast cancer samples, aneuploidy of tumor cells best correlated with cytoplasmic SIK distribution, and SIK expression correlated with TGFβ/Smad signaling activity and low or undetectable expression of Par3. Our model suggests that SIK can act directly on the polarity protein Par3 to regulate tight junction assembly. | |
650 | 7 | a NATURVETENSKAPx Biologix Biokemi och molekylärbiologi0 (SwePub)106022 hsv//swe |
650 | 7 | a NATURAL SCIENCESx Biological Sciencesx Biochemistry and Molecular Biology0 (SwePub)106022 hsv//eng |
650 | 7 | a NATURVETENSKAPx Biologix Cellbiologi0 (SwePub)106042 hsv//swe |
650 | 7 | a NATURAL SCIENCESx Biological Sciencesx Cell Biology0 (SwePub)106042 hsv//eng |
700 | 1 | a Dadras, Mahsa Shahidiu Uppsala universitet,Ludwiginstitutet för cancerforskning,Institutionen för medicinsk biokemi och mikrobiologi,Science for Life Laboratory, SciLifeLab4 aut0 (Swepub:uu)mahsh538 |
700 | 1 | a Lomnytska, Martau Uppsala universitet,Reproduktiv hälsa,Department of Oncology and Pathology, Karolinska Biomics Center, Karolinska Institute, Stockholm, Sweden4 aut0 (Swepub:uu)marlo829 |
700 | 1 | a Mahzabin, Tanzilau Uppsala universitet,Ludwiginstitutet för cancerforskning,Science for Life Laboratory, SciLifeLab,School of Anatomy, Physiology and Human Biology, The University of Western Australia, Crawley, WA, Australia4 aut |
700 | 1 | a Lee Miller, Martinu Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark; Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Center, Cambridge, UK4 aut |
700 | 1 | a Busch, Christeru Uppsala universitet,Institutionen för immunologi, genetik och patologi4 aut0 (Swepub:uu)chrbusch |
700 | 1 | a Brunak, Sørenu Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark4 aut |
700 | 1 | a Heldin, Carl-Henrik,d 1952-u Uppsala universitet,Science for Life Laboratory, SciLifeLab,Institutionen för medicinsk biokemi och mikrobiologi,Ludwiginstitutet för cancerforskning4 aut0 (Swepub:uu)carlheld |
700 | 1 | a Moustakas, Aristidisu Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi,Science for Life Laboratory, SciLifeLab,Ludwiginstitutet för cancerforskning4 aut0 (Swepub:uu)arimo287 |
710 | 2 | a Uppsala universitetb Science for Life Laboratory, SciLifeLab4 org |
773 | 0 | t Oncotargetd : Impact Journals, LLCg 9, s. 5716-5735q 9<5716-5735x 1949-2553 |
856 | 4 | u http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=23788&path%5B%5D=74849 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-334429 |
856 | 4 8 | u https://doi.org/10.18632/oncotarget.23788 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:229464029 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.